Cargando…

Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial

BACKGROUND: Little is known about satisfaction with different modes of telemedicine delivery. The objective of this study was to determine whether patient satisfaction with phone-only was noninferior to video visits. METHODS: We conducted a parallel group, randomized (1:1), single-blind, noninferior...

Descripción completa

Detalles Bibliográficos
Autores principales: Danila, Maria I., Sun, Dongmei, Jackson, Lesley E., Cutter, Gary, Jackson, Elizabeth A., Ford, Eric W., DeLaney, Erin, Mudano, Amy, Foster, Phillip J., Rosas, Giovanna, Melnick, Joshua A., Curtis, Jeffrey R., Saag, Kenneth G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446840/
https://www.ncbi.nlm.nih.gov/pubmed/35793732
http://dx.doi.org/10.1016/j.amjms.2022.06.021
_version_ 1784783728718905344
author Danila, Maria I.
Sun, Dongmei
Jackson, Lesley E.
Cutter, Gary
Jackson, Elizabeth A.
Ford, Eric W.
DeLaney, Erin
Mudano, Amy
Foster, Phillip J.
Rosas, Giovanna
Melnick, Joshua A.
Curtis, Jeffrey R.
Saag, Kenneth G.
author_facet Danila, Maria I.
Sun, Dongmei
Jackson, Lesley E.
Cutter, Gary
Jackson, Elizabeth A.
Ford, Eric W.
DeLaney, Erin
Mudano, Amy
Foster, Phillip J.
Rosas, Giovanna
Melnick, Joshua A.
Curtis, Jeffrey R.
Saag, Kenneth G.
author_sort Danila, Maria I.
collection PubMed
description BACKGROUND: Little is known about satisfaction with different modes of telemedicine delivery. The objective of this study was to determine whether patient satisfaction with phone-only was noninferior to video visits. METHODS: We conducted a parallel group, randomized (1:1), single-blind, noninferiority trial in multispecialty clinics at a tertiary academic medical center. Adults age ≥ 60 years or with Medicare/Medicaid insurance were eligible. Primary outcome was visit satisfaction rate (9 or 10 on a 0-10 satisfaction scale). Noninferiority was determined if satisfaction with phone-only (intervention) versus video visits (comparator) was no worse by a -15% prespecified noninferiority margin. We performed modified intent-to-treat (mITT) and per protocol analyses, after adjusting for age and insurance. RESULTS: 200 participants, 43% Black, 68% women completed surveys. Visit satisfaction rates were high. In the mITT analysis, phone-only visits were noninferior by an adjusted difference of 3.2% (95% CI, -7.6% to 14%). In the per protocol analysis, phone-only were noninferior by an adjusted difference of -4.1% (95% CI, -14.8% to 6.6%). The proportion of participants who indicated they preferred the same type of telemedicine visit as their next clinic visit were similar (30.2% vs 27.9% video vs phone-only, p = 0.78) and a majority said their medical concerns were addressed and would recommend a telemedicine visit. CONCLUSIONS: Among a group of diverse, established older or underserved patients, the satisfaction rate for phone-only was noninferior to video visits. These findings could impact practice and policies governing telemedicine.
format Online
Article
Text
id pubmed-9446840
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94468402022-09-06 Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial Danila, Maria I. Sun, Dongmei Jackson, Lesley E. Cutter, Gary Jackson, Elizabeth A. Ford, Eric W. DeLaney, Erin Mudano, Amy Foster, Phillip J. Rosas, Giovanna Melnick, Joshua A. Curtis, Jeffrey R. Saag, Kenneth G. Am J Med Sci Clinical Investigation BACKGROUND: Little is known about satisfaction with different modes of telemedicine delivery. The objective of this study was to determine whether patient satisfaction with phone-only was noninferior to video visits. METHODS: We conducted a parallel group, randomized (1:1), single-blind, noninferiority trial in multispecialty clinics at a tertiary academic medical center. Adults age ≥ 60 years or with Medicare/Medicaid insurance were eligible. Primary outcome was visit satisfaction rate (9 or 10 on a 0-10 satisfaction scale). Noninferiority was determined if satisfaction with phone-only (intervention) versus video visits (comparator) was no worse by a -15% prespecified noninferiority margin. We performed modified intent-to-treat (mITT) and per protocol analyses, after adjusting for age and insurance. RESULTS: 200 participants, 43% Black, 68% women completed surveys. Visit satisfaction rates were high. In the mITT analysis, phone-only visits were noninferior by an adjusted difference of 3.2% (95% CI, -7.6% to 14%). In the per protocol analysis, phone-only were noninferior by an adjusted difference of -4.1% (95% CI, -14.8% to 6.6%). The proportion of participants who indicated they preferred the same type of telemedicine visit as their next clinic visit were similar (30.2% vs 27.9% video vs phone-only, p = 0.78) and a majority said their medical concerns were addressed and would recommend a telemedicine visit. CONCLUSIONS: Among a group of diverse, established older or underserved patients, the satisfaction rate for phone-only was noninferior to video visits. These findings could impact practice and policies governing telemedicine. Elsevier 2022-11 2022-07-03 /pmc/articles/PMC9446840/ /pubmed/35793732 http://dx.doi.org/10.1016/j.amjms.2022.06.021 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Investigation
Danila, Maria I.
Sun, Dongmei
Jackson, Lesley E.
Cutter, Gary
Jackson, Elizabeth A.
Ford, Eric W.
DeLaney, Erin
Mudano, Amy
Foster, Phillip J.
Rosas, Giovanna
Melnick, Joshua A.
Curtis, Jeffrey R.
Saag, Kenneth G.
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial
title Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial
title_full Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial
title_fullStr Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial
title_full_unstemmed Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial
title_short Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial
title_sort satisfaction with modes of telemedicine delivery during covid-19: a randomized, single-blind, parallel group, noninferiority trial
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446840/
https://www.ncbi.nlm.nih.gov/pubmed/35793732
http://dx.doi.org/10.1016/j.amjms.2022.06.021
work_keys_str_mv AT danilamariai satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT sundongmei satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT jacksonlesleye satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT cuttergary satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT jacksonelizabetha satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT fordericw satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT delaneyerin satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT mudanoamy satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT fosterphillipj satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT rosasgiovanna satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT melnickjoshuaa satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT curtisjeffreyr satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial
AT saagkennethg satisfactionwithmodesoftelemedicinedeliveryduringcovid19arandomizedsingleblindparallelgroupnoninferioritytrial